• 대한상한금궤의학회지
• /
• v.14 no.1
• /
• pp.27-39
• /
• 2022

Objective : This study aimed to report the improvement of one patient with arrhythmia treated using Bokryeonggyejibaekchulgamcho-tang based on the disease pattern identification diagnostic system (DPIDS) by Shanhanlun Provisions. Methods : The patient with arrhythmia was treated using Bokryeonggyejibaekchulgamcho -tang according to to Shanghanlun provisions. The results were evaluated using Modified European Heart Rhythm Association symptom scale (mEHRA). Results : After taking Bokryeonggyejibaekchulgamcho-tang for 257 days, mEHRA decreased from 3 to 1. Conclusions : The Administration of Bokryeonggyejibaekchulgamcho-tang to patient with arrhythmia, based on Shanhanlun DPIDS was effective.

• 대한상한금궤의학회지
• /
• v.11 no.1
• /
• pp.103-111
• /
• 2019

Objective : The purpose of this study was to report the improvement in a patient with edema treated by herb medication based on Shanghanlun provisions. Methods : According to 'A disease pattern identification diagnostic system based on Shanghanlun provisions (DPIDS)', a patient was diagnosed with Taeyang-byung, no. 46 provision and was administered with Mahwang-tang herbal medication for 30 days. The Numeric rating scale (NRS) was used to estimate the response. Results : The NRS score changed from 10 to 1 and the edema disappeared by 46th provision of Mahwang-tang selected according to Shanghanlun provisions. Conclusions : This case report suggests that the two words in the 46th provision of Shanghanlun, '陽氣重, 無汗' (Yang qi heavy, Absence of sweating) indicate a close relationship between photosensitivity and absence of sweating, thereby affecting edema in this case.

• 대한상한금궤의학회지
• /
• v.14 no.1
• /
• pp.69-79
• /
• 2022

Objective : Fatigue is the most common symptom in post-COVID-19 syndrome. We report the case of a patient with post-COVID-19 syndrome with fatigue treated using herbal medicine (Saengkangsasim-tang). Methods : A 64-year-old man had severe fatigue for 4 months after a severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection. Saengkangsasim-tang was administered to this patient based on the disease pattern identification diagnostic system by Shanghanlun provisions (DPIDS). We used the Numeric Rating Scale (NRS) and Beck Depression Inventory (BDI) to evaluate the effectiveness of Saengkangsasim-tang for fatigue in the patient with post-COVID-19 syndrome. Results : According to DPIDS, the patient was diagnosed with the provision 157. After administration of Saengkangsasim-tang for 30days, the fatigue based on NRS and depression based on BDI were improved. Conclusions : The administration of Saengkangsasim-tang to patients with post-COVID-19 syndrome with fatigue, diagnosed according to the Shanghanlun provision 157, may be effective.